Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 8Gastrointestinal 4Thoracic 2Sarcoma 2Other solid neoplasm 2CNS 2Breast 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Leukemia 26Myelodysplastic Syndromes 22Leukemia, Myeloid, Acute 18Leukemia, Myeloid, Chronic-Phase 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Multiple Myeloma 11Hodgkin Disease 11Myeloproliferative Disorders 10Leukemia, Myeloid, Accelerated Phase 10Leukemia, Lymphocytic, Chronic, B-Cell 10Congenital Abnormalities 10Lymphoma 9Lymphoma, Non-Hodgkin 8Neoplasms, Plasma Cell 7Leukemia, Myelomonocytic, Chronic 7Blast Crisis 7Anemia, Refractory, with Excess of Blasts 7Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Primary Myelofibrosis 5Myelodysplastic-Myeloproliferative Diseases 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Burkitt Lymphoma 5Recurrence 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Monocytic, Acute 4

Interventions

fludarabine phosphate 4Cyclophosphamide 4Antilymphocyte Serum 4Mycophenolic Acid 3Filgrastim 3Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Cyclosporine 2Busulfan 2thymoglobulin 1sargramostim 1ixabepilone 1fludarabine 1cc-486 1aldesleukin 1Whole-Body Irradiation 1Voriconazole 1Stem Cell Transplantation 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Interleukin-12 Subunit p35 1Interferon-alpha 1Injections 1Immunotherapy 1Granulocyte Colony-Stimulating Factor 1Drug Therapy 1Cord Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × sargramostim × Myeloid × Clear all
NCT00003408 2013-03-26

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Teratoma, Testicular, Testicular Germ Cell Tumor, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Recurrence, Sarcoma, Sezary Syndrome, Teratoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡